I declare an interest as the chairman of the all-party group on off-patent drugs. I recently visited the Institute of Medical Genetics for Wales to see the excellent work being done there. May we have a debate on the future of personalised medicine, which is at the very cutting edge of research into cancer and rare diseases?
Business of the House
Business question from
Nick Thomas-Symonds
(Labour)
in the House of Commons on Thursday, 22 March 2018.
It occurred during Business statement on Business of the House.
Type
Proceeding contribution
Reference
638 c408
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2018-05-02 15:36:37 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-03-22/18032241000344
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-03-22/18032241000344
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-03-22/18032241000344